Marco F - Search Results

1

[Erythromycin-sensitive Streptococcus pyogenes].

Marco F, Mensa J, Almela M, Jiménez MT. Marco F, et al. Enferm Infecc Microbiol Clin. 1994 Dec;12(10):522. Enferm Infecc Microbiol Clin. 1994. PMID: 7865567 Spanish. No abstract available.

2

[Staphylococcus aureus bacteremia related to intravenous catheters].

Serrano-Heranz R, Mensa J, Almela M, Cruceta A, Moreno A, Marco F, Trilla A, Jiménez de Anta MT, Soriano E. Serrano-Heranz R, et al. Among authors: marco f. Enferm Infecc Microbiol Clin. 1992 Nov;10 Suppl 3:51-2. Enferm Infecc Microbiol Clin. 1992. PMID: 1477129 Spanish. No abstract available.

3

[Sepsis caused by Capnocytophaga ochracea in a patient with acute leukemia].

Marco F, Lozano M, Almela M, Bladé J, Jiménez de Anta MT. Marco F, et al. Enferm Infecc Microbiol Clin. 1989 Aug-Sep;7(7):394-6. Enferm Infecc Microbiol Clin. 1989. PMID: 2490471 Spanish. No abstract available.

4

[A community outbreak of Legionnaires' disease in Barcelona: clinical and microbiological study].

Monforte R, Estruch R, Vidal J, Mensa J, Marco F, Cervera R, Tarrero I, Jiménez de Anta MT, Urbano-Márquez A. Monforte R, et al. Among authors: marco f. Med Clin (Barc). 1989 Nov 4;93(14):521-5. Med Clin (Barc). 1989. PMID: 2622251 Spanish.

5

Therapeutic efficacy of the combination of aztreonam with cefotaxime in the treatment of severe nosocomial pneumonia. Comparative study against amikacin combined with cefotaxime.

Torres A, de Celis R, Rabinad E, Marco F, Almela M, Deulofeu R, Rodriguez-Roisin R, Agusti Vidal A. Torres A, et al. Among authors: marco f. Chemotherapy. 1989;35 Suppl 1:15-24. doi: 10.1159/000238716. Chemotherapy. 1989. PMID: 2659289 Clinical Trial.

6

[Pasteurella pneumotropica sepsis].

Casals C, Almela M, Marco F, Sort P. Casals C, et al. Among authors: marco f. Med Clin (Barc). 1995 Mar 11;104(9):358-9. Med Clin (Barc). 1995. PMID: 7731309 Spanish. No abstract available.

7

In vitro activity of clinafloxacin in comparison with other quinolones against Stenotrophomonas maltophilia clinical isolates in the presence and absence of reserpine.

Ribera A, Jurado A, Ruiz J, Marco F, Del Valle O, Mensa J, Chaves J, Hernández G, Jiménez de Anta MT, Vila J. Ribera A, et al. Among authors: marco f. Diagn Microbiol Infect Dis. 2002 Feb;42(2):123-8. doi: 10.1016/s0732-8893(01)00335-2. Diagn Microbiol Infect Dis. 2002. PMID: 11858908

8

Activity of clinafloxacin, compared with six other quinolones, against Acinetobacter baumannii clinical isolates.

Vila J, Ribera A, Marco F, Ruiz J, Mensa J, Chaves J, Hernandez G, Jimenez De Anta MT. Vila J, et al. Among authors: marco f. J Antimicrob Chemother. 2002 Mar;49(3):471-7. doi: 10.1093/jac/49.3.471. J Antimicrob Chemother. 2002. PMID: 11864947

9

High prevalence of nalidixic acid resistant, ciprofloxacin susceptible phenotype among clinical isolates of Escherichia coli and other Enterobacteriaceae.

Ruiz J, Gómez J, Navia MM, Ribera A, Sierra JM, Marco F, Mensa J, Vila J. Ruiz J, et al. Among authors: marco f. Diagn Microbiol Infect Dis. 2002 Apr;42(4):257-61. doi: 10.1016/s0732-8893(01)00357-1. Diagn Microbiol Infect Dis. 2002. PMID: 12007443

10

Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia.

Martínez JA, Horcajada JP, Almela M, Marco F, Soriano A, García E, Marco MA, Torres A, Mensa J. Martínez JA, et al. Among authors: marco ma, marco f. Clin Infect Dis. 2003 Feb 15;36(4):389-95. doi: 10.1086/367541. Epub 2003 Jan 31. Clin Infect Dis. 2003. PMID: 12567294

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,392 results

Search Page

Filters